Iceland vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Immunization, measles
Immunization, measles over time
- Iceland
- Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
How they compare
Iceland currently reports 97.0% against 83.6% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 13.4%.
That makes Iceland's figure about 1.2 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.
Across all 42 years both countries report, Iceland has been ahead every year.
Iceland ranks 31st and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 29th of 193 countries.
Iceland has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Iceland | Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 94.7% | 49.8% | 44.9% | Iceland |
| 1990s | 98.1% | 69.5% | 28.6% | Iceland |
| 2000s | 92.4% | 73.7% | 18.7% | Iceland |
| 2010s | 92.0% | 79.3% | 12.7% | Iceland |
| 2020s | 92.8% | 82.2% | 10.6% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles, Iceland or Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- Iceland, at 97.0% against 83.6% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2024.
- What is the difference in immunization, measles between Iceland and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- 13.4%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
- 42 years are reported by both, from 1983 to 2024.
- How do Iceland and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank globally for immunization, measles?
- Iceland ranks 31st and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 29th of 193 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, measles (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.